A detailed history of Geode Capital Management, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,357,531 shares of AGIO stock, worth $46.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,357,531
Previous 1,351,430 0.45%
Holding current value
$46.7 Million
Previous $58.3 Million 3.5%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$41.19 - $49.72 $251,300 - $303,341
6,101 Added 0.45%
1,357,531 $60.3 Million
Q2 2024

Aug 09, 2024

BUY
$27.55 - $48.83 $1.89 Million - $3.35 Million
68,515 Added 5.34%
1,351,430 $58.3 Million
Q1 2024

May 13, 2024

BUY
$21.32 - $34.81 $610,562 - $996,888
28,638 Added 2.28%
1,282,915 $37.5 Million
Q4 2023

Feb 13, 2024

BUY
$19.97 - $24.53 $1.1 Million - $1.36 Million
55,317 Added 4.61%
1,254,277 $27.9 Million
Q3 2023

Nov 13, 2023

BUY
$24.36 - $28.18 $1.01 Million - $1.16 Million
41,293 Added 3.57%
1,198,960 $29.7 Million
Q2 2023

Aug 11, 2023

BUY
$21.38 - $29.19 $1.46 Million - $1.99 Million
68,308 Added 6.27%
1,157,667 $32.8 Million
Q1 2023

May 15, 2023

BUY
$21.74 - $30.93 $734,833 - $1.05 Million
33,801 Added 3.2%
1,089,359 $25 Million
Q4 2022

Feb 13, 2023

BUY
$24.81 - $31.52 $708,970 - $900,715
28,576 Added 2.78%
1,055,558 $29.6 Million
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $1.89 Million - $3.31 Million
-97,022 Reduced 8.63%
1,026,982 $29 Million
Q2 2022

Aug 12, 2022

BUY
$17.06 - $31.42 $1.81 Million - $3.34 Million
106,324 Added 10.45%
1,124,004 $24.9 Million
Q1 2022

May 13, 2022

SELL
$26.68 - $34.81 $702,644 - $916,756
-26,336 Reduced 2.52%
1,017,680 $29.6 Million
Q4 2021

Feb 11, 2022

SELL
$29.58 - $49.78 $110,215 - $185,480
-3,726 Reduced 0.36%
1,044,016 $34.3 Million
Q3 2021

Nov 12, 2021

SELL
$41.92 - $58.18 $46,447 - $64,463
-1,108 Reduced 0.11%
1,047,742 $48.4 Million
Q2 2021

Aug 13, 2021

BUY
$52.06 - $61.27 $15.3 Million - $18 Million
294,468 Added 39.03%
1,048,850 $57.8 Million
Q1 2021

May 12, 2021

BUY
$44.23 - $57.5 $1.29 Million - $1.68 Million
29,151 Added 4.02%
754,382 $39 Million
Q4 2020

Feb 12, 2021

BUY
$33.21 - $46.54 $604,554 - $847,214
18,204 Added 2.57%
725,231 $31.4 Million
Q3 2020

Nov 13, 2020

SELL
$33.87 - $55.93 $969,562 - $1.6 Million
-28,626 Reduced 3.89%
707,027 $24.7 Million
Q2 2020

Aug 13, 2020

BUY
$34.45 - $53.48 $360,622 - $559,828
10,468 Added 1.44%
735,653 $39.3 Million
Q1 2020

May 14, 2020

BUY
$31.52 - $53.81 $1.33 Million - $2.28 Million
42,314 Added 6.2%
725,185 $25.7 Million
Q4 2019

Feb 13, 2020

BUY
$30.08 - $50.59 $2.88 Million - $4.85 Million
95,823 Added 16.32%
682,871 $32.6 Million
Q3 2019

Nov 12, 2019

BUY
$32.4 - $49.58 $229,748 - $351,571
7,091 Added 1.22%
587,048 $19 Million
Q2 2019

Aug 14, 2019

BUY
$46.17 - $68.1 $1.98 Million - $2.92 Million
42,922 Added 7.99%
579,957 $28.9 Million
Q1 2019

May 14, 2019

SELL
$45.92 - $67.67 $437,755 - $645,098
-9,533 Reduced 1.74%
537,035 $36.2 Million
Q4 2018

Feb 13, 2019

BUY
$42.73 - $76.53 $2.97 Million - $5.33 Million
69,603 Added 14.59%
546,568 $25.2 Million
Q3 2018

Nov 13, 2018

BUY
$71.67 - $91.95 $330,112 - $423,521
4,606 Added 0.98%
476,965 $36.8 Million
Q2 2018

Aug 14, 2018

BUY
$73.22 - $99.55 $3.57 Million - $4.85 Million
48,758 Added 11.51%
472,359 $39.8 Million
Q1 2018

May 15, 2018

BUY
$59.83 - $86.53 $3.24 Million - $4.68 Million
54,089 Added 14.64%
423,601 $34.6 Million
Q4 2017

Feb 13, 2018

BUY
$52.12 - $72.33 $212,284 - $294,600
4,073 Added 1.11%
369,512 $21.1 Million
Q3 2017

Nov 14, 2017

BUY
$54.89 - $67.12 $1.05 Million - $1.28 Million
19,050 Added 5.5%
365,439 $24.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
346,389
346,389 $17.8 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.88B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.